One-carbon metabolizing enzyme ALDH1L1 influences mitochondrial metabolism through 5-aminoimidazole-4-carboxamide ribonucleotide accumulation and serine depletion, contributing to tumor suppression.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
18 08 2023
18 08 2023
Historique:
received:
16
04
2023
accepted:
04
07
2023
medline:
21
8
2023
pubmed:
19
8
2023
entrez:
18
8
2023
Statut:
epublish
Résumé
Tumor cells generally require large amounts of nucleotides, and thus activate de novo purine synthesis (dnPS). In the dnPS reactions, 10-formyltetrahydorofolate (10-fTHF) supplied by one-carbon metabolism is utilized as a formyl group donor. We focused on aldehyde dehydrogenase 1 family member L1 (ALDH1L1), which metabolizes 10-fTHF to tetrahydrofolate and whose expression is often attenuated in hepatocellular carcinoma (HCC). We generated ALDH1L1-expressing HuH-7 cells to perform metabolome analysis and found that intracellular levels of serine were reduced and glycine was increased. In addition, 5-aminoimidazole-4-carboxamide ribonucleotide (ZMP), a dnPS intermediate, accumulated due to the consumption of 10-fTHF by ALDH1L1, which inhibited ZMP formylation. Importantly, ALDH1L1-expressing cells showed reduced ZMP sensitivity and higher mitochondrial activity. The suppression of mitochondrial serine catabolism by ALDH1L1 expression was speculated to be closely related to this phenotype. Gene set enrichment analysis utilizing The Cancer Genome Atlas data revealed that genes related to oxidative phosphorylation were enriched in HCC patients with high ALDH1L1 expression. Moreover, drug sensitivity data analysis demonstrated that HCC cell lines with low expression of ALDH1L1 were sensitive to ZMP and cordycepin, a structural analog of ZMP and AMP. Our study revealed that ZMP and AMP analogs might be effective in the pharmacotherapy of HCC patients with low expression of ALDH1L1.
Identifiants
pubmed: 37596270
doi: 10.1038/s41598-023-38142-5
pii: 10.1038/s41598-023-38142-5
pmc: PMC10439146
doi:
Substances chimiques
AICA ribonucleotide
F0X88YW0YK
4-aminoimidazole
4919-03-3
Ribonucleotides
0
Carbon
7440-44-0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
13486Informations de copyright
© 2023. Springer Nature Limited.
Références
Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).
doi: 10.3322/caac.21660
pubmed: 33538338
Altekruse, S. F. et al. Histological classification of liver and intrahepatic bile duct cancers in SEER registries. J. Regist. Manag. 38, 201–205 (2011).
Craig, A. J. et al. Tumour evolution in hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol. 17, 139–152 (2020).
doi: 10.1038/s41575-019-0229-4
pubmed: 31792430
Bialecki, E. S. & Di Bisceglie, A. M. Diagnosis of hepatocellular carcinoma. HPB (Oxford) 7, 26–34 (2005).
doi: 10.1080/13651820410024049
pubmed: 18333158
Bertuccio, P. et al. Global trends and predictions in hepatocellular carcinoma mortality. J. Hepatol. 67, 302–309 (2017).
doi: 10.1016/j.jhep.2017.03.011
pubmed: 28336466
Pareek, V., Pedley, A. & Benkovic, S. Human de novo purine biosynthesis. Crit. Rev. Biochem. Mol. Biol. 56, 1–16 (2021).
doi: 10.1080/10409238.2020.1832438
pubmed: 33179964
Camici, M., Allegrini, S. & Tozzi, M. G. Interplay between adenylate metabolizing enzymes and AMP-activated protein kinase. FEBS J. 285, 3337–3352 (2018).
doi: 10.1111/febs.14508
pubmed: 29775996
Keerthana, C. K. et al. The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment. Front. Immunol. 14, 1114582. https://doi.org/10.3389/fimmu.2023.1114582 (2023).
doi: 10.3389/fimmu.2023.1114582
pubmed: 36875093
pmcid: 9975160
Pan, S. et al. Serine, glycine and one-carbon metabolism in cancer (Review). Int. J. Oncol. 58, 158–170 (2021).
doi: 10.3892/ijo.2020.5158
pubmed: 33491748
Li, A. M. & Ye, J. Reprogramming of serine, glycine and one-carbon metabolism in cancer. Biochim. Biophys. Acta Mol. Basis Dis. 1866, 165841. https://doi.org/10.1016/j.bbadis.2020.165841 (2022).
doi: 10.1016/j.bbadis.2020.165841
Xiu, Y. & Field, M. S. The roles of mitochondrial folate metabolism in supporting mitochondrial DNA synthesis, oxidative phosphorylation, and cellular function. Curr. Dev. Nutr. 4, 1–9. https://doi.org/10.1093/cdn/nzaa153 (2020).
doi: 10.1093/cdn/nzaa153
Oleinik, N. V., Krupenko, N. I. & Krupenko, S. A. Epigenetic silencing of ALDH1L1, a metabolic regulator of cellular proliferation in Cancers. Genes Cancer 2, 130–139 (2011).
doi: 10.1177/1947601911405841
pubmed: 21779486
pmcid: 3111244
Chen, X. Q., He, J. R. & Wang, H. Y. Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma. Med. Oncol. 29, 1843–1849 (2012).
doi: 10.1007/s12032-011-0075-x
pubmed: 21987076
Kondo, K. et al. Surgical strategy for hepatocellular carcinoma patients with portal vein tumor thrombus based on prognostic factors. J. Gastrointest. Surg. 13, 1078–1083 (2009).
doi: 10.1007/s11605-009-0854-2
pubmed: 19296182
Liao, X. et al. Genome-wide association study identified PLCE1- rs2797992 and EGFR- rs6950826 were associated with TP53 expression in the HBV-related hepatocellular carcinoma of Chinese patients in Guangxi. Am. J. Transl. Res. 8, 1799–1812 (2016).
pubmed: 27186304
pmcid: 4859909
Zhu, G. et al. ALDH1L1 variant rs2276724 and mRNA expression predict post-operative clinical outcomes and are associated with TP53 expression in HBV-related hepatocellular carcinoma. Oncol. Rep. 38, 1451–1463 (2017).
doi: 10.3892/or.2017.5822
pubmed: 28714006
pmcid: 5549030
Krupenko, S. A. & Krupenko, N. I. Loss of ALDH1L1 folate enzyme confers a selective metabolic advantage for tumor progression. Chem. Biol. Interact. 302, 149–155 (2019).
doi: 10.1016/j.cbi.2019.02.013
pubmed: 30794800
pmcid: 6433412
Krupenko, N. I. et al. Cytosolic 10- formyltetrahydrofolate dehydrogenase regulates glycine metabolism in mouse liver. Sci. Rep. 9, 14937. https://doi.org/10.1038/s41598-019-51397-1 (2019).
doi: 10.1038/s41598-019-51397-1
pubmed: 31624291
pmcid: 6797707
Krupenko, N. I. et al. Knockout of putative tumor suppressor Aldh1l1 in mice reprograms metabolism to accelerate growth of tumors in a diethylnitrosamine (DEN) model of liver carcinogenesis. Cancers 13, 3219. https://doi.org/10.3390/cancers13133219 (2021).
doi: 10.3390/cancers13133219
pubmed: 34203215
pmcid: 8268287
Sharma, J. et al. Sex-specific metabolic effects of dietary folate withdrawal in wild-type and Aldh1l1 knockout mice. Metabolites 12, 454. https://doi.org/10.3390/metabo12050454 (2022).
doi: 10.3390/metabo12050454
pubmed: 35629957
pmcid: 9143804
Human Protein Atlas proteinatlas.org: https://www.proteinatlas.org
Slater, T. F., Sawyer, B. & Straeuli, U. Studies on succinate-tetrazolium reductase systems. III. Points of coupling of four different tetrazolium salts. Biochim. Biophys. Acta. 77, 383–393 (1963).
doi: 10.1016/0006-3002(63)90513-4
pubmed: 14089413
Boison, D. Adenosine kinase: Exploitation for therapeutic gain. Pharmacol. Rev. 65, 906–943 (2013).
doi: 10.1124/pr.112.006361
pubmed: 23592612
pmcid: 3698936
Hebbard, L. & George, J. Animal models of nonalcoholic fatty liver disease. Nat. Rev. Gastroenterol. Hepatol. 8, 35–44 (2011).
doi: 10.1038/nrgastro.2010.191
pubmed: 21119613
Tong, J. et al. Cancer proteome and metabolite changes linked to SHMT2. PLoS ONE 15, e0237981. https://doi.org/10.1371/journal.pone.0237981 (2020).
doi: 10.1371/journal.pone.0237981
pubmed: 32903271
pmcid: 7480864
Guigas, S. et al. AMP-activated protein kinase-independent inhibition of hepatic mitochondrial oxidative phosphorylation by AICA riboside. Biochem. J. 404, 499–507 (2007).
doi: 10.1042/BJ20070105
pubmed: 17324122
pmcid: 1896274
Carbognin, E. et al. Stat3 promotes mitochondrial transcription and oxidative respiration during maintenance and induction of naive pluripotency. EMBO J. 35, 618–634 (2016).
doi: 10.15252/embj.201592629
pubmed: 26903601
pmcid: 4801951
Ehinger, J. K. et al. Cell-permeable succinate prodrugs bypass mitochondrial complex I deficiency. Nat. Commun. 7, 12317. https://doi.org/10.1038/ncomms12317 (2016).
doi: 10.1038/ncomms12317
pubmed: 27502960
pmcid: 4980488
Hofer, A. et al. Defining the action spectrum of potential PGC-1α activators on a mitochondrial and cellular level in vivo. Hum. Mol. Genet. 23, 2400–2425 (2014).
doi: 10.1093/hmg/ddt631
pubmed: 24334768
Zhao, R. Z. et al. Mitochondrial electron transport chain, ROS generation and uncoupling. Int. J. Mol. Med. 44, 3–15 (2019).
pubmed: 31115493
pmcid: 6559295
Lucas, S. et al. Serine catabolism is essential to maintain mitochondrial respiration in mammalian cells. Life Sci. Alliance 1, e201800036. https://doi.org/10.26508/lsa.201800036 (2018).
doi: 10.26508/lsa.201800036
pubmed: 30456347
pmcid: 6238390
Danise, R. et al. Serine catabolism by SHMT2 is required for proper mitochondrial translation initiation and maintenance of formylmethionyl-tRNAs. Mol. Cell 69, 610–621 (2018).
doi: 10.1016/j.molcel.2018.01.024
Morscher, R. J. et al. Mitochondrial translation requires folate-dependent tRNA methylation. Nature 554, 128–132 (2018).
doi: 10.1038/nature25460
pubmed: 29364879
pmcid: 6020024
Tani, H. et al. Mice deficient in the Shmt2 gene have mitochondrial respiration defects and are embryonic lethal. Sci. Rep. 8, 425. https://doi.org/10.1038/s41598-017-18828-3 (2018).
doi: 10.1038/s41598-017-18828-3
pubmed: 29323231
pmcid: 5765156
Hirschenson, J., Melgar-Bermudez, E. & Mailloux, R. J. The uncoupling proteins: A systematic review on the mechanism used in the prevention of oxidative stress. Antioxidants 11, 322. https://doi.org/10.3390/antiox11020322 (2022).
doi: 10.3390/antiox11020322
pubmed: 35204205
pmcid: 8868465
Brand, M. D. & Esteves, T. C. Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3. Cell Metab. 2, 85–93 (2005).
doi: 10.1016/j.cmet.2005.06.002
pubmed: 16098826
Brand, M. D. et al. The basal proton conductance of mitochondria depends on adenine nucleotide translocase content. Biochem. J. 392, 353–362 (2005).
doi: 10.1042/BJ20050890
pubmed: 16076285
pmcid: 1316271
Man, S. et al. Potential and promising anticancer drugs from adenosine and its analogs. Drug Discov. Today 26, 1490–1500 (2021).
doi: 10.1016/j.drudis.2021.02.020
pubmed: 33639248
Hoadley, K. A. et al. Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer. Cell 173, 291–304 (2018).
doi: 10.1016/j.cell.2018.03.022
pubmed: 29625048
pmcid: 5957518
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 102, 15545–15550 (2005).
doi: 10.1073/pnas.0506580102
pubmed: 16199517
pmcid: 1239896
Ge, S. X., Son, E. W. & Yao, R. iDEP: An integrated web application for differential expression and pathway analysis of RNA-Seq data. BMC Bioinform. 19, 534. https://doi.org/10.1186/s12859-018-2486-6 (2018).
doi: 10.1186/s12859-018-2486-6
Sud, M. et al. Metabolomics workbench: An international repository for metabolomics data and metadata, metabolite standards, protocols, tutorials and training, and analysis tools. Nucleic Acids Res. 44, D463-470 (2016).
doi: 10.1093/nar/gkv1042
pubmed: 26467476